New results from the National Institutes of Health's Researching COVID to Enhance Recovery (RECOVER)-Adult Initiative suggest that 4.5% of COVID-19 survivors have myalgic encephalomyelitis/chronic ...
A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis (TB), researchers reported this week in the New ...